ATE421968T1 - Metallnanostrukturen und pharmazeutische zusammensetzungen - Google Patents
Metallnanostrukturen und pharmazeutische zusammensetzungenInfo
- Publication number
- ATE421968T1 ATE421968T1 AT06013913T AT06013913T ATE421968T1 AT E421968 T1 ATE421968 T1 AT E421968T1 AT 06013913 T AT06013913 T AT 06013913T AT 06013913 T AT06013913 T AT 06013913T AT E421968 T1 ATE421968 T1 AT E421968T1
- Authority
- AT
- Austria
- Prior art keywords
- pharmaceutical compositions
- metal core
- nanometric
- metal nanostructures
- gold
- Prior art date
Links
- 229910052751 metal Inorganic materials 0.000 title abstract 6
- 239000002184 metal Substances 0.000 title abstract 6
- 239000002086 nanomaterial Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000004332 silver Substances 0.000 abstract 2
- 125000006850 spacer group Chemical group 0.000 abstract 2
- 229910001316 Ag alloy Inorganic materials 0.000 abstract 1
- 229910001020 Au alloy Inorganic materials 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 125000003636 chemical group Chemical group 0.000 abstract 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052737 gold Inorganic materials 0.000 abstract 1
- 239000010931 gold Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000002209 hydrophobic effect Effects 0.000 abstract 1
- 229910052709 silver Inorganic materials 0.000 abstract 1
- 239000000758 substrate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
- A61K47/6923—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere the form being an inorganic particle, e.g. ceramic particles, silica particles, ferrite or synsorb
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/05—Metallic powder characterised by the size or surface area of the particles
- B22F1/054—Nanosized particles
- B22F1/0553—Complex form nanoparticles, e.g. prism, pyramid, octahedron
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F1/00—Metallic powder; Treatment of metallic powder, e.g. to facilitate working or to improve properties
- B22F1/10—Metallic powder containing lubricating or binding agents; Metallic powder containing organic material
- B22F1/102—Metallic powder coated with organic material
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F1/00—Compounds containing elements of Groups 1 or 11 of the Periodic Table
- C07F1/005—Compounds containing elements of Groups 1 or 11 of the Periodic Table without C-Metal linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nanotechnology (AREA)
- Health & Medical Sciences (AREA)
- Inorganic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Ceramic Engineering (AREA)
- Composite Materials (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Materials Engineering (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69657605P | 2005-07-05 | 2005-07-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE421968T1 true ATE421968T1 (de) | 2009-02-15 |
Family
ID=37072258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06013913T ATE421968T1 (de) | 2005-07-05 | 2006-07-05 | Metallnanostrukturen und pharmazeutische zusammensetzungen |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20070116773A1 (de) |
| EP (1) | EP1741717B1 (de) |
| AT (1) | ATE421968T1 (de) |
| DE (1) | DE602006005026D1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2636908T3 (es) | 2010-04-27 | 2017-10-10 | Ventana Medical Systems, Inc. | Conjugados de nanopartícula-anticuerpo y procedimientos para producir y usar dichos conjugados |
| US8956440B2 (en) * | 2011-03-18 | 2015-02-17 | William Marsh Rice University | High-yield synthesis of gold nanorods with optical absorption at wavelengths greater than 1000nm using hydroquinone |
| FR2978066B1 (fr) * | 2011-07-22 | 2016-01-15 | Commissariat Energie Atomique | Procede de fonctionnalisation de nanofils metalliques et de fabrication d'electrodes |
| CN102488524A (zh) * | 2011-11-29 | 2012-06-13 | 武汉大学 | 基于金纳米棒的近红外光吸收成像方法 |
| PL399505A1 (pl) * | 2012-06-13 | 2013-12-23 | Uniwersytet Warszawski | Sposób wytwarzania zasadniczo czystych nanoczastek w ukladzie przeplywowym, nanoczastki otrzymane tym sposobem oraz ich zastosowanie |
| EP3310342A4 (de) * | 2015-06-16 | 2019-03-06 | The Trustees of the University of Pennsylvania | Anorganische retard-partikel mit schneller wirkstoffbeladung |
| JP6692042B2 (ja) * | 2016-09-16 | 2020-05-13 | 大日本塗料株式会社 | 表面上の第四級アンモニウムカチオン並びに／又は金及び／若しくは銀のハロゲン化物の量が低減された金ナノ粒子の懸濁液 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6319674B1 (en) * | 1999-09-16 | 2001-11-20 | Agilent Technologies, Inc. | Methods for attaching substances to surfaces |
| US7695738B2 (en) * | 2003-02-19 | 2010-04-13 | Academia Sinica | Carbohydrate encapsulated nanoparticles |
-
2006
- 2006-06-30 US US11/479,388 patent/US20070116773A1/en not_active Abandoned
- 2006-07-05 EP EP06013913A patent/EP1741717B1/de not_active Not-in-force
- 2006-07-05 DE DE602006005026T patent/DE602006005026D1/de active Active
- 2006-07-05 AT AT06013913T patent/ATE421968T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20070116773A1 (en) | 2007-05-24 |
| DE602006005026D1 (de) | 2009-03-19 |
| EP1741717A1 (de) | 2007-01-10 |
| EP1741717B1 (de) | 2009-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE421968T1 (de) | Metallnanostrukturen und pharmazeutische zusammensetzungen | |
| Varghese Alex et al. | Green synthesized Ag nanoparticles for bio-sensing and photocatalytic applications | |
| Levard et al. | Sulfidation processes of PVP-coated silver nanoparticles in aqueous solution: impact on dissolution rate | |
| Kim et al. | Development of label-free colorimetric assay for MERS-CoV using gold nanoparticles | |
| Zheng et al. | Antimicrobial gold nanoclusters | |
| Singh et al. | Competitive inhibition of the enzyme-mimic activity of Gd-based nanorods toward highly specific colorimetric sensing of l-cysteine | |
| Li et al. | Effects of chloride ions on dissolution, ROS generation, and toxicity of silver nanoparticles under UV irradiation | |
| Reinsch et al. | Sulfidation of silver nanoparticles decreases Escherichia coli growth inhibition | |
| Duan et al. | Robust antibacterial activity of tungsten oxide (WO3-x) nanodots | |
| Li et al. | Dissolution-accompanied aggregation kinetics of silver nanoparticles | |
| Li et al. | DNA-templated self-assembly of protein and nanoparticle linear arrays | |
| Nadagouda et al. | Green synthesis of Au nanostructures at room temperature using biodegradable plant surfactants | |
| El Badawy et al. | Surface charge-dependent toxicity of silver nanoparticles | |
| Gondikas et al. | Cysteine-induced modifications of zero-valent silver nanomaterials: implications for particle surface chemistry, aggregation, dissolution, and silver speciation | |
| Wigginton et al. | Binding of silver nanoparticles to bacterial proteins depends on surface modifications and inhibits enzymatic activity | |
| Liu et al. | Kinetics and mechanisms of nanosilver oxysulfidation | |
| Wang et al. | Silver nanoparticles induced RNA polymerase-silver binding and RNA transcription inhibition in erythroid progenitor cells | |
| Xiu et al. | Differential effect of common ligands and molecular oxygen on antimicrobial activity of silver nanoparticles versus silver ions | |
| Liu et al. | Optimization of high-yield biological synthesis of single-crystalline gold nanoplates | |
| Popat et al. | Surface modification of nanoporous alumina surfaces with poly (ethylene glycol) | |
| Li et al. | Synthesis of monodisperse, quasi-spherical silver nanoparticles with sizes defined by the nature of silver precursors | |
| ATE405300T1 (de) | Zusammengesetzte materialien aus metall beladenen abgeblätterten nanoteilchen | |
| Rusen et al. | Design of antimicrobial membrane based on polymer colloids/multiwall carbon nanotubes hybrid material with silver nanoparticles | |
| DK1631318T3 (da) | Magnetiske nanopartikler bundet til en ligand | |
| WO2007092030A3 (en) | Tungsten comprising nanomaterials and related nanotechnology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |